Transferrin Receptor, Soluble
The transferrin receptor (TfR) is expressed on the surface of human cells that require iron and is the carrier protein for transferrin. When transferrin binds to the receptor on the cell surface, the receptor-transferrin complex is taken into the cell by endocytosis. The endocytotic vesicle is acidified and as a result the two iron atoms carried by transferrin are released into the cell. TfR is regulated by the concentration of iron within the cell and is critical to importing iron into the cell. The receptor is essential for the cell to properly bind iron. Almost all cells have TfR, but they are particularly concentrated on immature erythroid cells in the bone marrow, placental cells and liver cells. The concentration of soluble TfR (sTfR) has been reported to be proportional to the total amount of cell-associated TfR. sTfR level increases in iron deficiency. An sTfR level may be useful in combination with other tests of iron status in differentiating iron deficiency anemia from anemia of chronic disease since sTfR is more accurate than ferritin in differentiating anemia of chronic disorders from iron deficiency anemia.
A diagnostic algorithm that combines the results of ferritin and sTfR has been proposed. A patient with a ferritin of less than or equal to 10 g/L is considered iron deficient regardless of sTfR level. A patient with ferritin equal to or greater than 220 g/L is considered not iron deficient. For ferritin values between 10 and 220 g/L, levels of sTfR may be used to identify iron-deficient patients.
- Diagnosis of iron deficiency
- Differential diagnosis of iron deficiency anemia from anemia of chronic disorders
- Estimation of total erythropoiesis
- Evaluation of iron restricted erythropoiesis
- Erythropoietin therapy monitoring
Increased in:
- Iron deficiency anemia
- Conditions of high red cell turnover (e.g., hemolytic anemia)
- Some erythrocyte proliferative disorders
Decreased in:
- Aplastic anemia
- Chronic renal failure
- Post-organ transplant anemia
| Group | mg/L | g/L |
| Adult | 2.9–3.8 | 0.0029–0.0038 |
| Infants | ||
| 1 year | 4.5–11.1 | 0.0045–0.0111 |
| Prepubertal Male | ||
| Age 11–12 years | 4.7–9.2 | 0.0047–0.0092 |
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Annu Rev Med. 1993;44:63-74. [PMID: 8476268]
- Am J Med Sci. 1999 Oct;318(4):269-76. [PMID: 10522554]
- Adv Exp Med Biol. 1994;352:119-26. [PMID: 7832041]
- Ann Biol Clin (Paris). 1999 Jan-Feb;57(1):9-18. [PMID: 992096]
- Blood Cells Mol Dis. 2002 Nov-Dec;29(3):498-505. [PMID: 12547240]
- Int J Hematol. 2002 Oct;76(3):213-8. [PMID: 12416731]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757